Target type: biologicalprocess
The regionalization process in which information that determines the correct position at which animal organ primordia are formed is generated and perceived resulting in correct positioning of the new animal organ. [GOC:curators]
The specification of animal organ position is a complex and tightly regulated process that involves a series of intricate molecular and cellular interactions. It is orchestrated by a combination of intrinsic genetic programs, extrinsic signaling cues, and mechanical forces, all working in concert to ensure the precise placement of organs within the developing embryo.
**1. Early Patterning and Axis Formation:**
The initial blueprint for organ positioning is laid down during early embryonic development with the establishment of the body axes - the anterior-posterior (head to tail), dorsal-ventral (back to belly), and left-right axes. This is achieved through the interplay of maternal factors, transcription factors, and signaling pathways. For instance, the Wnt signaling pathway plays a crucial role in establishing the anterior-posterior axis, while the BMP signaling pathway is involved in dorsal-ventral patterning.
**2. Organ Primordium Formation:**
Once the basic body plan is established, specific regions of the embryo become committed to developing into particular organs. This process of organ primordium formation involves the activation of specific gene expression programs within these regions, leading to the formation of distinct cell populations with specific identities.
**3. Morphogenesis and Organ Positioning:**
The organ primordia then undergo a series of morphogenetic movements, including cell migration, proliferation, and differentiation, to attain their final shapes and positions. These movements are often guided by signaling molecules and extracellular matrix components, which provide cues for cell migration and adhesion.
**4. Interplay of Signaling Pathways:**
Multiple signaling pathways, including Wnt, Shh, FGF, and BMP, are involved in organ positioning. These pathways act in a coordinated manner, often influencing each other's activities, to ensure the precise placement of organs. For instance, the Shh signaling pathway is crucial for the proper development of the limbs and the nervous system, while FGF signaling is involved in heart and lung development.
**5. Mechanical Forces and Cell-Cell Interactions:**
Mechanical forces, such as cell-cell adhesion, tension, and compression, also play a significant role in organ positioning. These forces can shape tissues and organs and help to guide their movements during development.
**6. Genetic Control:**
Mutations in genes involved in any of these processes can lead to defects in organ positioning, resulting in developmental abnormalities. For instance, mutations in genes encoding components of the Wnt or Shh signaling pathways can cause a range of congenital defects, including malformations of the heart, limbs, and brain.
**7. Environmental Influences:**
While genetic factors play a major role in organ positioning, environmental factors, such as nutrition and exposure to toxins, can also influence the process. These factors can affect gene expression and signaling pathways, potentially leading to developmental abnormalities.
In summary, the specification of animal organ position is a highly complex and integrated process that involves a precise interplay of genetic, molecular, and mechanical factors. Understanding the underlying mechanisms of this process is crucial for addressing birth defects and for developing new strategies for tissue regeneration and organ transplantation.'
"
Protein | Definition | Taxonomy |
---|---|---|
Bone morphogenetic protein 4 | A bone morphogenetic protein 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P12644] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dorsomorphin | dorsomorphin : A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling. dorsomorphin: an AMPK inhibitor | aromatic ether; piperidines; pyrazolopyrimidine; pyridines | bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor |
ldn 193189 | LDN 193189: inhibits bone morphogenetic protein signaling | pyrimidines | |
ml347 | ML347: an ALK2 inhibitor; structure in first source |